Learn More about lung cancer question builder

The Caring Ambassadors Program provides this website to help you and your loved ones
understand your disease and some of the health care options available to you.

Our three main methods to fight lung cancer are to Empower patients and providers with access to free educational materials, and resources; to Educate communities about the importance of screening and to share current information with patients and their families; and to Advocate for access to screening and treatment for lung cancer for all communities. Knowledge empowers you to ask the necessary questions to become your own best advocate. When your questions have been asked and answered, you and your health care providers will be in the best possible situation to determine the best treatment approach for you.

Learn More about lung cancer question builder

Caring Ambassadors is proud to have Lung Cancer Choices included in the National Comprehensive Cancer Network Patient Resources

Learn More about lung cancer question builder

Lung Cancer Choices,© 6th Edition can be a useful tool for anyone who is caring for someone with lung cancer, but its primary focus is on the patient. This book is suitable for both the newly diagnosed and those who have been living with lung cancer for some time.

MY CHOICES© is a tool to help you recognize and act upon what you can control in your health care journey to achieve optimal healing, regardless of the illness you face. It contains elements of a guide book, health planner, journal, and activity book to help orient you to and plan for the journey ahead.

Caregiver Choices© is a resource for all those who find themselves in the role of caregiver for someone who has been diagnosed with lung cancer.

Weekly News Update. Caring Ambassadors Program provides 3 weekly news updates covering Lung Cancer News, Hepatitis C News, and My Choices© Update. Receive them delivered weekly to your inbox.

Weekly News Update

Lung Cancer News

Week Ending February 19, 2024

Tagrisso with the addition of chemotherapy approved in the US for patients with EGFR-mutated advanced lung cancer
“AstraZeneca’s has been approved in the US for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). The approval following a Priority Review by the Food and Drug Administration (FDA) was based on the results from the FLAURA2 Phase III trial published in The New England Journal of Medicine. Tagrisso with the addition of chemotherapy reduced the risk of disease progression or death by 38% compared to Tagrisso monotherapy which is the 1st-line global standard of care (hazard ratio [HR] 0.62; 95% confidence interval [CI] 0.49-0.79; p<0.0001). Median progression-free survival (PFS) by investigator assessment was 25.5 months for patients treated with Tagrisso plus chemotherapy, an 8.8-month improvement versus Tagrisso monotherapy (16.7 months).”

Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study
“Risk-based screening strategies are more efficient in reducing lung cancer deaths and gaining life years compared to the status quo strategy. Risk-stratified screening intervals can potentially balance long-term benefit–harm trade-offs and improve the cost-effectiveness of lung cancer screenings.”

FDA Accepts Dato-DXd Application for Non-Small Cell Lung Cancer
“The BLA for Dato-DXd, a TROP2-directed ADC, in previously treated, advanced, nonsquamous NSCLC has been accepted by the FDA, and a PDUFA target action date is anticipated in the fourth quarter of 2024.”

Reflex Molecular Testing May Enhance Targeted Therapy Benefit in Early-Stage Lung Cancer
“Efforts to standardize and implement reflex testing for biomarkers in early-stage non–small cell lung cancer could allow for earlier identification of appropriate targeted therapies that may be used in treatment, thereby improving patient outcomes, according to Jobelle Baldonado, MD, who adds that it is important for surgical oncologists to stay up to date on the development of targeted agents in lung cancer so they can best treat patients presenting with recurrent disease.”

Work-Related Respirable Crystalline Silica Exposure and Lung Cancer Risk
“Prevention measures should be taken to protect workers who are exposed to respirable crystalline silica (RCS) from lung cancer risk. Researchers assessed a systemic review of 20 studies found using the PubMed database and an online search of RCS limits set by institutional organizations. They sought to determine the cutoff points that could affect risk of mortality or incidence of lung cancer from occupational RCS exposure.”

Osimertinib Yields Activity, Manageable Toxicity in Metastatic EGFR+ NSCLC
“Treatment with osimertinib (Tagrisso) demonstrated clinical activity and a manageable safety profile among patients with metastatic non–small cell lung cancer (NSCLC) harboring EGFR mutations outside of exon 20 insertion mutations, according to findings from the phase 2 UNICORN trial (jRCTs071200002) published in JAMA Oncology.”

‘Help is right here’: Roswell Park brings lung cancer screening to people who need it
“Eddy is Roswell Park Comprehensive Cancer Center’s new mobile lung cancer screening unit – the size of a tractor-trailer – and its mission is in its name: “Early Detection Driven to You.”

Kentucky rises to No. 2 in the nation in screening for lung cancer, which lowers the chances that the disease will be fatal
“Dr. Tony Stumbo’s heart sank after the doctor shared his mother’s chest X-ray. “I remember that drive home, bringing her back home, and we basically cried,” said the internal medicine physician, who had started practicing in Eastern Kentucky near his childhood home in Floyd County shortly before his mother began feeling ill. “Nobody wants to get told they’ve got inoperable lung cancer. I cried because I knew what this meant for her.” Now Stumbo, whose mother died the following year, in 1997, is among a group of Kentucky clinicians and researchers determined to rewrite the script for other families by promoting training and boosting awareness about early detection in the state with the highest lung cancer death rate.”

Study Finds New Inhalable Therapy is a Big Step Forward in Lung Cancer Research
“Newswise — Lung cancer is one of the most common cancers and has one of the lowest survival rates in the world. Cytokines, which are small signaling proteins, such as interleukin-12 (IL-12), have demonstrated considerable potential as robust tumor suppressors. However, their applications are limited due to a multitude of severe side effects.”

Video:

Doctors warn of rise in lung cancer among non-smokers
“One Triad woman was diagnosed at 30 years old. There are three warning signs that you should see a doctor.”

Treatment-Specific Biomarkers, Future of Research for Lung Cancer with Jonathan Spicer, MD, PhD
“In this Lungcast segment, Spicer spoke on several treatment-specific biomarkers for lung cancer and discussed the future of lung cancer therapy.”

My Choices© News Update

Week Ending February 19, 2024

Redefining Cancer: A New Approach to Early Stage Diseases
“The understanding of disease biology for many cancer types has significantly advanced in recent years. However, this progress is not always mirrored in the way cancer is defined and treated. This can lead to overdiagnosis and overtreatment, particularly in cancers such as ductal carcinoma in situ (DCIS) and low-grade prostate cancer, which pose minimal risks for mortality or diminished quality of life.”

Scientists Tame Shapeless Monster Behind 75% of Cancers
“Researchers at UC Riverside have made a groundbreaking discovery in cancer treatment by developing a peptide that can control MYC, a key protein involved in the majority of human cancers. This innovation offers new hope for targeting cancer at a molecular level, paving the way for more effective treatments.”

Revolutionizing Recovery: Ottawa Study Unveils VR Mindfulness as a Beacon for Veterans
“In Ottawa, a revolutionary study by the University of Ottawa uncovers the transformative potential of VR mindfulness training for veterans grappling with substance use recovery. This immersive approach enhances mood, state mindfulness, and overall well-being, shedding light on promising therapeutic interventions for mental health.”

Tai chi reduces blood pressure better than aerobic exercise, study finds
“Tai chi, a traditional, slow-moving form of Chinese martial art, is known to increase flexibility and improve balance. Now, new research suggests it’s better than more vigorous aerobic exercises for lowering blood pressure in people with prehypertension.”

How Exercise Can Help Boost Your Memory
“Forgetting information. Losing focus. Having difficulty doing tasks you used to find easy, like following a recipe or running errands. Struggling to remember the word for that thing…”

Exercise unleashes anti-inflammatory power against autoimmune diseases
“In a recent study published in Journal of Sport and Health Science, a group of researchers evaluated the impact of exercise training on reducing inflammation in adolescents and adults with autoimmune diseases through a systematic review of studies published over two decades.”

Women may get more health benefits from regular exercise than men
“Men and women who exercise regularly are less likely to die prematurely of any cause, including a cardiovascular event, compared to those who are sedentary. Researchers also report that women see more pronounced benefits than men from regular exercise. They added that exercise routines should contain both aerobic exercise and strength training.”

How To Get Sculpted Arms Like Miley Cyrus
“Do you feel like your arms could do with a serious tune-up but can’t afford a personal trainer or gym fees? We share a celebrity-inspired workout you can carry out at home without the celebrity price tag.”

Monday Medical: How integrative medicine can improve your health
“The more physicians and patients explore the many ways integrative medicine can be used to promote health and healing, the more it has become an integral component of American health care. “Both physicians and patients just need to have an open mind,” said Dr. Nicole Cotter, a board-certified rheumatologist and integrative medicine physician at UCHealth Yampa Valley Medical Center. “Every patient can benefit from integrative medicine, and every physician can benefit from introducing elements of it into treating patients. In fact, primary care physicians are probably doing it more than their patients realize. Many people aren’t familiar with the name ‘integrative medicine,’ even though they are likely using it in one form or another.” Surveys show that 40% of Americans participate in some type of integrative medicine. It combines traditional or conventional medical practices with complementary medicine modalities, so patients receive the best of both approaches.”

Tell Congress: Fair Funding for Lung Cancer Research!

$25 million for lung cancer research is included in the House defense spending bill for fiscal year (FY) 2024, but it’s not a done deal.

Congress is still working to finalize appropriations for FY 2024, which began on October 1.

Lung cancer patients can’t wait.

Click below to send a message to your congressional representatives asking them to pass a final spending deal that includes $25 million for the Lung Cancer Research Program at the Department of Defense.

Tell your representatives not to leave lung cancer research behind! 

Help Open People’s Eyes.

Would you be so kind as to share a snippet about your lung cancer experience with us?

There is no right way to share – talk, write, draw, speak poetry – just please SHARE. Email us: MyStory@CaringAmbassadors.org